Biblio

Export 476 results:
[ Author(Desc)] Title Type Year
Filters: Keyword is Alzheimer Disease  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
M
A. Manousopoulou, Saito, S., Yamamoto, Y., Al-Daghri, N. M., Ihara, M., Carare, R. O., and Garbis, S. D., Hemisphere Asymmetry of Response to Pharmacologic Treatment in an Alzheimer's Disease Mouse Model., J Alzheimers Dis, vol. 51, no. 2, pp. 333-8, 2016.
Y. Manso, Comes, G., López-Ramos, J. C., Belfiore, M., Molinero, A., Giralt, M., Carrasco, J., Adlard, P. A., Bush, A. I., Delgado-García, J. María, and Hidalgo, J., Overexpression of Metallothionein-1 Modulates the Phenotype of the Tg2576 Mouse Model of Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 1, pp. 81-95, 2016.
P. R. Manzine, Pelucchi, S., Horst, M. A., Vale, F. A. C., Pavarini, S. C. I., Audano, M., Mitro, N., Di Luca, M., Marcello, E., and Cominetti, M. R., microRNA 221 Targets ADAM10 mRNA and is Downregulated in Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 1, pp. 113-123, 2018.
M. Mapstone, Cheema, A. K., Fiandaca, M. S., Zhong, X., Mhyre, T. R., MacArthur, L. H., Hall, W. J., Fisher, S. G., Peterson, D. R., Haley, J. M., Nazar, M. D., Rich, S. A., Berlau, D. J., Peltz, C. B., Tan, M. T., Kawas, C. H., and Federoff, H. J., Plasma phospholipids identify antecedent memory impairment in older adults., Nat Med, vol. 20, no. 4, pp. 415-8, 2014.
C. Marra, Gainotti, G., Fadda, L., Perri, R., Lacidogna, G., Scaricamazza, E., Piccininni, C., and Quaranta, D., Usefulness of an Integrated Analysis of Different Memory Tasks to Predict the Progression from Mild Cognitive Impairment to Alzheimer's Disease: The Episodic Memory Score (EMS)., J Alzheimers Dis, vol. 50, no. 1, pp. 61-70, 2016.
E. J. Mason, Hussey, E. P., Molitor, R. J., Ko, P. C., Donahue, M. J., and Ally, B. A., Family History of Alzheimer's Disease is Associated with Impaired Perceptual Discrimination of Novel Objects., J Alzheimers Dis, vol. 57, no. 3, pp. 735-745, 2017.
J. A. Matías-Guiu, Pytel, V., and Matías-Guiu, J., Death Rate Due to COVID-19 in Alzheimer's Disease and Frontotemporal Dementia., J Alzheimers Dis, vol. 78, no. 2, pp. 537-541, 2020.
J. A. Matías-Guiu, Cabrera-Martín, M. Nieves, Curiel, R. E., Valles-Salgado, M., Rognoni, T., Moreno-Ramos, T., Carreras, J. Luis, Loewenstein, D. A., and Matías-Guiu, J., Comparison between FCSRT and LASSI-L to Detect Early Stage Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 1, pp. 103-111, 2018.
E. G. McGeer and McGeer, P. L., Neuroinflammation in Alzheimer's disease and mild cognitive impairment: a field in its infancy., J Alzheimers Dis, vol. 19, no. 1, pp. 355-61, 2010.
B. McGuinness, Fuchs, M., Barrett, S. L., A Passmore, P., and Johnston, J. A., Platelet Membrane β-Secretase Activity in Mild Cognitive Impairment and Conversion to Dementia: a Longitudinal Study., J Alzheimers Dis, vol. 49, no. 4, pp. 1095-103, 2016.
G. M. McKhann, Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., Mohs, R. C., Morris, J. C., Rossor, M. N., Scheltens, P., Carrillo, M. C., Thies, B., Weintraub, S., and Phelps, C. H., The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease., Alzheimers Dement, vol. 7, no. 3, pp. 263-9, 2011.
P. Mecocci, Boccardi, V., Cecchetti, R., Bastiani, P., Scamosci, M., Ruggiero, C., and Baroni, M., A Long Journey into Aging, Brain Aging, and Alzheimer's Disease Following the Oxidative Stress Tracks., J Alzheimers Dis, vol. 62, no. 3, pp. 1319-1335, 2018.
A. Medoro, Bartollino, S., Mignogna, D., Passarella, D., Porcile, C., Pagano, A., Florio, T., Nizzari, M., Guerra, G., Di Marco, R., Intrieri, M., Raimo, G., and Russo, C., Complexity and Selectivity of γ-Secretase Cleavage on Multiple Substrates: Consequences in Alzheimer's Disease and Cancer., J Alzheimers Dis, vol. 61, no. 1, pp. 1-15, 2018.
K. E. Melah, Lu, S. Yuan- Fu, Hoscheidt, S. M., Alexander, A. L., Adluru, N., Destiche, D. J., Carlsson, C. M., Zetterberg, H., Blennow, K., Okonkwo, O. C., Gleason, C. E., N Dowling, M., Bratzke, L. C., Rowley, H. A., Sager, M. A., Asthana, S., Johnson, S. C., and Bendlin, B. B., Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease., J Alzheimers Dis, vol. 50, no. 3, pp. 873-86, 2016.
S. Merighi, Battistello, E., Casetta, I., Gragnaniello, D., Poloni, T. Emanuele, Medici, V., Cirrincione, A., Varani, K., Vincenzi, F., Borea, P. Andrea, and Gessi, S., Upregulation of Cortical A2A Adenosine Receptors Is Reflected in Platelets of Patients with Alzheimer's Disease., J Alzheimers Dis, vol. 80, no. 3, pp. 1105-1117, 2021.
K. Metsla, Kirss, S., Laks, K., Sildnik, G., Palgi, M., Palumaa, T., Tõugu, V., and Palumaa, P., α-Lipoic Acid Has the Potential to Normalize Copper Metabolism, Which Is Dysregulated in Alzheimer's Disease., J Alzheimers Dis, vol. 85, no. 2, pp. 715-728, 2022.
R. Migliaccio, Gallea, C., Kas, A., Perlbarg, V., Samri, D., Trotta, L., Michon, A., Lacomblez, L., Dubois, B., Lehéricy, S., and Bartolomeo, P., Functional Connectivity of Ventral and Dorsal Visual Streams in Posterior Cortical Atrophy., J Alzheimers Dis, vol. 51, no. 4, pp. 1119-30, 2016.
J. A. Miller, Horvath, S., and Geschwind, D. H., Divergence of human and mouse brain transcriptome highlights Alzheimer disease pathways., Proc Natl Acad Sci U S A, vol. 107, no. 28, pp. 12698-703, 2010.
R. Milne, Bunnik, E., Diaz, A., Richard, E., Badger, S., Gove, D., Georges, J., Fauria, K., Molinuevo, J. - L., Wells, K., Ritchie, C., and Brayne, C., Perspectives on Communicating Biomarker-Based Assessments of Alzheimer's Disease to Cognitively Healthy Individuals., J Alzheimers Dis, vol. 62, no. 2, pp. 487-498, 2018.
H. K. Mohseni and Chettle, D. R., A History of In Vivo Neutron Activation Analysis in Measurement of Aluminum in Human Subjects., J Alzheimers Dis, vol. 50, no. 4, pp. 913-26, 2016.
A. Montesanto, Crocco, P., Anfossi, M., Smirne, N., Puccio, G., Colao, R., Maletta, R., Passarino, G., Bruni, A. C., and Rose, G., The Genetic Variability of UCP4 Affects the Individual Susceptibility to Late-Onset Alzheimer's Disease and Modifies the Disease's Risk in APOE-ɛ4 Carriers., J Alzheimers Dis, vol. 51, no. 4, pp. 1265-74, 2016.
Y. Moon, Han, S. - H., and Moon, W. - J., Patterns of Brain Iron Accumulation in Vascular Dementia and Alzheimer's Dementia Using Quantitative Susceptibility Mapping Imaging., J Alzheimers Dis, vol. 51, no. 3, pp. 737-45, 2016.
J. - P. Morin, Cerón-Solano, G., Velázquez-Campos, G., Pacheco-López, G., Bermúdez-Rattoni, F., and Díaz-Cintra, S., Spatial Memory Impairment is Associated with Intraneural Amyloid-β Immunoreactivity and Dysfunctional Arc Expression in the Hippocampal-CA3 Region of a Transgenic Mouse Model of Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 1, pp. 69-79, 2016.
J. C. Morris, Roe, C. M., Xiong, C., Fagan, A. M., Goate, A. M., Holtzman, D. M., and Mintun, M. A., APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging., Ann Neurol, vol. 67, no. 1, pp. 122-31, 2010.
D. E. Moss, Perez, R. G., and Kobayashi, H., Cholinesterase Inhibitor Therapy in Alzheimer's Disease: The Limits and Tolerability of Irreversible CNS-Selective Acetylcholinesterase Inhibition in Primates., J Alzheimers Dis, vol. 55, no. 3, pp. 1285-1294, 2017.

Pages